home / stock / xers / xers news


XERS News and Press, Xeris Pharmaceuticals Inc. From 08/26/21

Stock Information

Company Name: Xeris Pharmaceuticals Inc.
Stock Symbol: XERS
Market: NASDAQ

Menu

XERS XERS Quote XERS Short XERS News XERS Articles XERS Message Board
Get XERS Alerts

News, Short Squeeze, Breakout and More Instantly...

XERS - Top Penny Stocks Analysts Say To Buy, Targets Up To 200% Right Now

Analysts Say These Are Penny Stocks To Buy Right Now; Do You Agree? Penny stocks are well-known for their high risk. But ask any trader in 2021 and you’ll also see how many look to buy these cheap stocks for their potential rewards. Just look at the last 2 weeks, for instance. We...

XERS - CARA, CLXT, TBPH and XERS among after hours movers

Gainers: CARA +24.3%. CLXT +5.9%. ABNB +3.9%. AMTX +3.9%. ACIU +2.4%. Losers: TBPH -24.1%. XERS -3.0%. CPOP -2.7%. MRIN -2.6%. ALVR -2.1%. For further details see: CARA, CLXT, TBPH and XERS among after hours movers

XERS - Trillium Therapeutics, Vivos Therapeutics leads healthcare gainers; Flora Growth, Surgalign among major losers

Gainers: Trillium Therapeutics (NASDAQ:TRIL) +187%, Vivos Therapeutics (NASDAQ:VVOS) +57%, Xeris Pharmaceuticals (NASDAQ:XERS) +19%, ALX Oncology (NASDAQ:ALXO) +24%, Candel Therapeutics (NASDAQ:CADL) +20%. Losers: Flora Growth (NASDAQ:FLGC) -10%,&#...

XERS - Trending Penny Stocks To Buy For Under $3 Right Now

Penny Stocks To Buy For Less Than A Cup Of Coffee; Are They Worth It? What are penny stocks? According to the basic Securities & Exchange Commission definition, these are stocks that can be bought for under $5 a share. When you’re talking about low prices, there are a few thi...

XERS - Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke® Kit for the Treatment of Severe Hypoglycemia

First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue Gvoke HypoPen®, Gvoke® PFS, and Gvoke® Kit – three different administration options to accommodate patients’ preferences Gvoke Kit eliminates the ...

XERS - Xeris Pharmaceuticals Strengthens Its Patent Estate

Patents and patent applications provide additional coverage for XeriSol™ and XeriJect™ technology platforms Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize r...

XERS - Merger Arbitrage Mondays - BAMR Acquires American National Group At A Large Premium

Two rumored deals materialize at very large premiums. In a battle of railroads, Canadian Pacific comes back but gets rejected by Kansas City Southern. SPACs fire up with 17 new IPOs filed just last week. For further details see: Merger Arbitrage Mondays - BAMR Acquires A...

XERS - Xeris Pharmaceuticals Achieves Unprecedented Levels of Payor Coverage for Gvoke®

Over 240 million lives have unrestricted access 3 million Illinois Medicaid lives to be added effective Oct 1st Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize rea...

XERS - Xeris Pharmaceuticals Announces FDA Acceptance of its IND Application for XeriSol(TM) Levothyroxine (XP-8121) for the Treatment of Hypothyroidism

Currently recruiting healthy participants Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the...

XERS - Merger Arbitrage Mondays - Veoneer Receives A Superior Bid From Qualcomm

Six multi-billion dollar deals announced last week. VICI Properties acquires MGM Growth Properties for $17.2 billion. Veoneer receives a superior bid from Qualcomm. For further details see: Merger Arbitrage Mondays - Veoneer Receives A Superior Bid From Qualcomm

Previous 10 Next 10